Alcohol ADME in Primates Studied with Positron Emission Tomography

Researchers have developed an innovative way to automatically and reliably detect and monitor medication "on" and "off" states in Parkinson's disease patients.

Alzheimer’s is a disease of aggregation. Neurons in the human brain make a protein called amyloid beta. Now, a team led by researchers at the University of Washington has developed synthetic peptides that target and inhibit those small, toxic aggregates.

Researchers combine CRISPR gene-editing technology with drug discovery to understand why treatment works (or doesn’t).